Background
Methods
Patients
Feature | Data |
---|---|
Age, years | 56.4 (14.8) |
Disease duration, years | 7.5 (8.5) |
mRSS, points | 11.1 (11.0) |
Sex, male/female, n (%) | 22 (18)/100 (82) |
Subset, lcSSc/dcSSc, n (%) | 81 (66)/41 (34) |
Ab, ACA/ATA/ARA/ANA+/ANA−, n (%) | 34 (28)/22 (18)/17 (14)/40 (33)/9 (7) |
Clinical data
Measurement of complement activation markers
Haemolytic assays
Immunohistochemical staining of C3
Statistical analysis
Results
The complement system is activated in patients with autoimmune diseases
Correlations of complement activation markers in patients with autoimmune diseases
Disease | C4d-TCC correlation | C3bBbP-TCC correlation | C4d-C3bBbP correlation | |||
---|---|---|---|---|---|---|
Spearman’s r
|
p value | Spearman’s r
|
p value | Spearman’s r
|
p value | |
SSc (n = 122) | −0.06 | 0.47 | 0.47 | <0.0001a
| 0.099 | 0.27 |
RA (n = 81) | 0.12 | 0.29 | 0.41 | 0.0001a
| 0.26 | 0.018b
|
PsoA (n = 22) | 0.035 | 0.88 | 0.52 | 0.013b
| 0.086 | 0.70 |
AS (n = 20) | −0.33 | 0.15 | 0.52 | 0.019b
| −0.20 | 0.40 |
Correlations of complement activation markers to mRSS and COMP
n
| C4d |
p value | C3bBbP |
p value | TCC |
p value | |
---|---|---|---|---|---|---|---|
Age | 122 | −0.14 | 0.13 | −0.083 | 0.36 | 0.017 | 0.86 |
mRSS | 118 | 0.17 | 0.06 | −0.16 | 0.087 | −0.082 | 0.38 |
COMP | 53 | 0.16 | 0.26 | −0.052 | 0.71 | 0.092 | 0.51 |
Analyses of complement activation markers in the subgroups of patients with SSc
n
| C4d, mean (SD) |
p value | C3bBbP, mean (SD) |
p value | TCC, mean (SD) |
p value | |
---|---|---|---|---|---|---|---|
Sex | 0.96 | 0.20 | 0.87 | ||||
Male | 22 | 35.6 (40.3) | 913 (574) | 5.80 (3.69) | |||
Female | 100 | 29.2 (18.3) | 1119 (661) | 8.39 (15.8) | |||
Subset | 0.88 | 0.11 | 0.36 | ||||
lcSSc | 81 | 30.1 (25.2) | 1143 (655) | 8.56 (16.4) | |||
dcSSc | 41 | 30.8 (20.7) | 962 (629) | 6.66 (9.34) | |||
PAH | 0.19 | 0.75 | 0.76 | ||||
No | 96 | 31.8 (25.3) | 1069 (645) | 7.50 (12.4) | |||
Yes | 26 | 25.0 (16.0) | 1131 (676) | 9.49 (20.5) | |||
SRC | 0.036 | <0.001 | 0.003 | ||||
No | 104 | 28.9 (23.7) | 1156 (655) | 8.57 (15.4) | |||
Yes | 18 | 38.6 (22.9) | 656 (423) | 4.22 (5.54) | |||
Ab | 0.095 | 0.055 | 0.016 | ||||
ACA | 34 | 30.7 (16.9) | 1029 (594) | 5.83 (5.70) | |||
ATA | 22 | 32.7 (18.8) | 1140 (744) | 10.8 (22.0) | |||
ARA | 17 | 35.0 (22.5) | 761 (560) | 3.19 (2.59) | |||
ANA+
| 40 | 29.5 (32.2) | 1195 (642) | 10.6 (18.0) | |||
ANA−
| 9 | 18.1 (10.0) | 1244 (705) | 5.62 (3.36) | |||
Pitting scar | 0.50 | 0.35 | 0.76 | ||||
No | 68 | 31.0 (26.1) | 1071 (658) | 9.30 (18.6) | |||
Yes | 50 | 28.6 (19.0) | 1155 (633) | 6.53 (5.62) | |||
Ulcer | 0.35 | 0.36 | 0.54 | ||||
No | 105 | 30.5 (23.9) | 1090 (656) | 8.31 (15.3) | |||
Yes | 14 | 25.5 (17.8) | 1183 (574) | 6.19 (6.53) | |||
Telangiectasias | 0.83 | 0.19 | 0.39 | ||||
No | 56 | 28.5 (17.8) | 1003 (586) | 6.07 (3.80) | |||
Yes | 63 | 31.2 (27.2) | 1189 (687) | 9.84 (19.6) |